A carregar...
Patients with normal-range CA19-9 levels represent a distinct subgroup of pancreatic cancer patients
Pancreatic cancer remains a lethal disease that responds poorly to multiple types of treatment. Therefore, the identification of distinct subgroups that exhibit unique therapeutic responses is an urgent requirement. In the present multicenter study (1,912 cases), the differences between the therapeu...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351346/ https://ncbi.nlm.nih.gov/pubmed/28356973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5501 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|